Lancet Formally Retracts Jikei Heart Study of Novartis AG (NVS)'s Diovan
9/6/2013 8:10:57 AM
The Lancet has formally retracted the Jikei Heart Study paper, originally published in 2007. The retraction had been widely anticipated for more than a month, after a series of news reports in Japan made it clear that the long-simmering controversy over scientific misconduct involving the Novartis NVS +0.4% blood pressure lowering drug valsartan (Diovan) had come to a full boil. As reported previously, the current scandal first began to unfold in late 2011 when a Japanese blogger pointed to a number of apparent errors in publications authored by Hiroaki Matsubara.
Help employers find you! Check out all the jobs and post your resume.
comments powered by